New insulin study seeks to understand how it works with other foods in type 1 diabetes
NCT ID NCT07305805
First seen Jan 04, 2026 · Last updated May 23, 2026 · Updated 20 times
Summary
This early-stage study is testing a new insulin called NNC0363-1063 in people with type 1 diabetes. Researchers want to see how it interacts with a non-glucose carbohydrate found in food and drink, and whether taking them together is safe. About 36 adults aged 18-64 will receive the insulin and different amounts of the carbohydrate in random order over 4 sessions. The study lasts 5 to 12 weeks and focuses on safety and how the body responds.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Profil Institut für Stoffwechselforschung GmbH
RECRUITINGNeuss, 41460, Germany
Conditions
Explore the condition pages connected to this study.